RenaMed Biologics' Series E Round

RenaMed Biologics raised a round of funding on September 21, 2006.

RenaMed Biologics, a University of Michigan spin-out from the late 90s, is a clinical stage cellular therapy company dedicated to the design, development, and commercialization of human cell replaceme…

Articles about RenaMed Biologics' Series E Round: